Back

Notification report


Full notification file


General information

Notification Number
B/NL/11/006

Member State to which the notification was sent
Netherlands

Date of acknowledgement from the Member State Competent Authority
05/10/2012

Title of the Project
Vaccination of chickens with a combination vaccine against infectious laryngotracheitis (ILT) and Marek’s disease (MD)

Proposed period of release:
05/10/2012 to 31/12/2016

Name of the Institute(s) or Company(ies)
Intervet International bv, Boxmeer, The Netherlands;


3. Is the same GMO release planned elsewhere in the Community?
Yes:
Spain;

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
The Innovax-ILT vaccine contains the live cell-associated Herpesvirus of Turkey (HVT) strain HVT/ILT-138 in a cell-associated form. This is a vector vaccine: the HVT/ILT-138 virus strain was generated by inserting glycoprotein genes of Infectious Laryngotracheitis virus (ILTV) into the HVT strain FC-126 genome.
HVT belongs to the virus family Herpesviridae, subfamily Alphaherpesvirinae, genus "Marek's disease-like viruses" (also knows as the genus Mardivirus).


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HVTMardivirusMeleagrid herpesvirus 1-FC-126-

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known